{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:33:57Z","timestamp":1789576437874,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ajem.2017.08.044","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T03:45:20Z","timestamp":1503546320000},"page":"1928-1933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Emergency department approach to QTc prolongation"],"prefix":"10.1016","volume":"35","author":[{"given":"Ali","family":"Pourmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Chistov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Sabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Vukomanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almulhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2017.08.044_bb0005","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.289.16.2120","article-title":"What clinicians should know about the QT interval","volume":"289","author":"Al-Khatib","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2017.08.044_bb0010","series-title":"Long QT syndromes and torsade de pointes","first-page":"1625","volume":"354","author":"Viskin","year":"1999"},{"key":"10.1016\/j.ajem.2017.08.044_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/212178","article-title":"Management of acquired comprehensive review","volume":"2011","author":"Kallergis","year":"2012","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.ajem.2017.08.044_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003264","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","author":"Vandenberk","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajem.2017.08.044_bb0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2017.08.044_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cpcardiol.2008.07.002","article-title":"Long QT syndrome","volume":"33","author":"Goldenberg","year":"2008","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0035","author":"Committee for Proprietary Medicinal Products"},{"key":"10.1016\/j.ajem.2017.08.044_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ajem.2017.08.044_bb0045","author":"U.S. Department of Health and Human Services, Food and Drug Administration"},{"key":"10.1016\/j.ajem.2017.08.044_bb0050","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","article-title":"Sudden cardiac death","volume":"98","author":"Zipes","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2017.08.044_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2005.08.067","article-title":"Prolonged QTc interval and risk of sudden cardiac death in a population of older adults","volume":"47","author":"Straus","year":"2006","journal-title":"Coll Cardiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0060","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.CIR.83.6.1888","article-title":"QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest","volume":"83","author":"Algra","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2017.08.044_bb0065","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ajem.2017.08.044_bb0070","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.111.080887","article-title":"Clinical and genetic determinants of torsade de pointes risk","volume":"125","author":"Sauer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2017.08.044_bb0075","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI25539","article-title":"Genetics of acquired long QT syndrome","volume":"115","author":"Roden","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajem.2017.08.044_bb0080","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacc.2005.09.056","article-title":"Effect of clinical phenotype on yield of long QT syndrome genetic testing","volume":"47","author":"Tester","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"van Noord","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0090","first-page":"435","article-title":"Bradycardia-induced torsade de pointes - an arrhythmia less understood","volume":"10","author":"Namboodiri","year":"2010","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.ajem.2017.08.044_bb0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/hrt.79.1.56","article-title":"Relation between bradycardia dependent long QT syndrome and QT prolongation by disopyramide in humans","volume":"79","author":"Furushima","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.ajem.2017.08.044_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1755-5922.12054","article-title":"Antibiotic-induced cardiac arrhythmias","volume":"32","author":"Abo-Salem","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ajem.2017.08.044_bb0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/49.4.593","article-title":"Cardiotoxicity of fluoroquinolones","volume":"49","author":"Rubinstein","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajem.2017.08.044_bb0110","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pds.1746","article-title":"Drug-induced torsades de pointes: data mining of the public version of the FDA adverse event reporting system (AERS)","volume":"18","author":"Poluzzi","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajem.2017.08.044_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1152\/physrev.00005.2004","article-title":"Inherited and acquired vulnerability to ventricular arrhythmias: cardiac Na+ and K+ channels","volume":"85","author":"Clancy","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajem.2017.08.044_bb0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccep.2016.02.004","article-title":"Mechanism of proarrhythmic effects of potassium channel blockers","volume":"8","author":"Skibsbye","year":"2016","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.ajem.2017.08.044_bb0130","first-page":"209","article-title":"Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome","volume":"15","author":"Riera","year":"2008","journal-title":"Cardiol J"},{"key":"10.1016\/j.ajem.2017.08.044_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.annemergmed.2013.10.026","article-title":"Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis","volume":"64","author":"Freedman","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0140","author":"FDA Drug Safety Communication"},{"key":"10.1016\/j.ajem.2017.08.044_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0019-5049.108560","article-title":"Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: a prospective single-blind randomised trial","volume":"57","author":"Ganjare","year":"2013","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.ajem.2017.08.044_bb0150","first-page":"326","article-title":"A randomized controlled trial of intravenous haloperidol vs. intravenous metoclopramide for acute migraine therapy in the emergency department. J","volume":"49","author":"Gaffigan","year":"2015","journal-title":"Emerg Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0976-9668.82306","article-title":"Evaluation of ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis","volume":"2","author":"Gupta","year":"2011","journal-title":"J Nat Sci Biol Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0160","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajem.2017.08.044_bb0165","first-page":"53","article-title":"Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study","volume":"3","author":"Hafermann","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.ajem.2017.08.044_bb0170","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajem.2017.08.044_bb0175","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","article-title":"Antipsychotic-related QTc prolongation, torsade de pointes and sudden death","volume":"62","author":"Haddad","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ajem.2017.08.044_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/JCP.0b013e318191c6a8","article-title":"Psychotropic drugs associated with corrected QT interval prolongation","volume":"29","author":"Van Noord","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajem.2008.04.020","article-title":"A systematic review of cardiovascular effects after atypical antipsychotic medication overdose","volume":"27","author":"Tan","year":"2009","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajem.2014.09.048","article-title":"Risk factors for QT prolongation associated with acute psychotropic drug overdose","volume":"33","author":"Miura","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0195","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.ajem.2017.08.044_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","article-title":"American Academy of emergency medicine position statement: safety of droperidol use in the emergency department","volume":"49","author":"Perkins","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2017.08.044_bb0205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2146\/ajhp070279","article-title":"Association of antipsychotic and antidepressant drugs with Q-T interval prolongation","volume":"65","author":"Zemrak","year":"2008","journal-title":"Am J Heal Pharm"},{"key":"10.1016\/j.ajem.2017.08.044_bb0210","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2017.08.044_bb0215","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.hrthm.2014.08.026","article-title":"New formula for evaluation of the QT interval in patients with left bundle branch block","volume":"11","author":"Bogossian","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ajem.2017.08.044_bb0220","first-page":"22(2)","article-title":"A new experimentally validated formula to calculate the QT interval in the presence of left bundle branch block holds true in the clinical setting","author":"Bogossian","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/pace.13027","article-title":"Applicability of a novel formula (Bogossian formula) for evaluation of the QT-interval in heart failure and left bundle branch block due to right ventricular pacing","volume":"40","author":"Frommeyer","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0230","first-page":"56","article-title":"QT tendency in pacemaker dependent patients prognostic meaning of long QTc during 5 year follow up","volume":"253","author":"Tsetskhladze","year":"2016","journal-title":"Georgian Med News"},{"key":"10.1016\/j.ajem.2017.08.044_bb0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/15563650.2015.1013547","article-title":"Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region","volume":"53","author":"Othong","year":"2015","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004320","article-title":"Validation of the prognostic utility of the electrocardiogram for acute drug overdose","volume":"6","author":"Manini","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajem.2017.08.044_bb0245","author":"University of Arizona, Center for Education and Research on Therapeutics"},{"key":"10.1016\/j.ajem.2017.08.044_bb0250","first-page":"5040176","article-title":"Loperamide induced life threatening ventricular arrhythmia","volume":"2016","author":"Upadhyay","year":"2016","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcp.12726","article-title":"Pharmacological treatment of acquired QT prolongation and torsades de pointes","volume":"81","author":"Thomas","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0260","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ihj.2013.12.021","article-title":"Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies","volume":"66","author":"Jaiswal","year":"2014","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ajem.2017.08.044_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1542-474X.2006.00098.x","article-title":"An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence","volume":"11","author":"McBride","year":"2006","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.ajem.2017.08.044_bb0270","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/ajhp\/60.22.2308","article-title":"Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter","volume":"60","author":"Kalus","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajem.2017.08.044_bb0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00044011-199713050-00001","article-title":"Prolonged magnesium sulfate infusion in the treatment of ventricular tachycardia in acquired long QT syndrome","volume":"13","author":"Perticone","year":"1997","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ajem.2017.08.044_bb0280","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/eurheartj\/ehl199","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary","volume":"27","author":"Zipes","year":"2006","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675717306939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675717306939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:37:52Z","timestamp":1760024272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675717306939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0735675717306939"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2017.08.044","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency department approach to QTc prolongation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2017.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}